Key ADDITIONS TO THE PDL. Antineoplastics and Adjunctive Therapies; Antimetabolites. Antiparkinson Agents; Antiparkinson Dopaminergics

Size: px
Start display at page:

Download "Key ADDITIONS TO THE PDL. Antineoplastics and Adjunctive Therapies; Antimetabolites. Antiparkinson Agents; Antiparkinson Dopaminergics"

Transcription

1 July 15, 2014 Dear Provider: UPDATE WellCare of South Carolina Preferred Drug List At the April 24, 2014 and June 26, 2014 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be made to the WellCare of South Carolina Medicaid Preferred Drug List (), effective August 26, Please carefully review these changes. UPPER CASE = Brand Name Drugs Lower case italics = Generic Drugs = Preferred Drug List Effective date of change: August 26, 2014 Key PA = Prior Authorization QL = Quantity Limits ST = Step Therapy Drug Name Therapeutic Class Change ADRUCIL 50 mg/ml solution for injection ADDITIONS TO THE Antimetabolites Added to the w/ PA Alternative (if applicable) ALLEGRA-D 12 HOUR ALLERGY & CONGESTION amantadine hydrochloride 100 mg aspirin 81 mg enteric coated AVASTIN solution for injection all cetirizine hydrochloride hydrochloride syrup - all Decongestant & Antihistamine Antiparkinson Agents; Antiparkinson Dopaminergics Analgesics - Nonnarcotic; Salicylates Antineoplastics - Angiogenesis Inhibitors; Vascular Endothelial Growth Factor Inhibitors Antihistamines; Non- Sedating Added to the Added to the Added to the Added to the w/ PA Added to the w/ QL (300 ml/31 days) Page 1 of 18

2 Drug Name Therapeutic Class Change Alternative CHLOR-TRIMETON - all Antihistamines; Alkylamines Added to the CONDYLOX 0.5 % topical gel dexmethylphenidate hydrochloride - all diazepam 5 mg/5 ml vials, disp syringes DIMAPHEN DM COLD/COUGH CHILDRENS elixir DIMETAPP LONG ACTING COUGH PLUS COLD syrup erythromycin 2% gel escitalopram oxalate - all estazolam 1 mg 2 mg fexofenadine hydrochloride - all fluoxetine hydrochloride capsules, - all Dermatologicals; Keratolytic/Antimitotic Agents ADHD/Anti- Narcolepsy/Anti- Obesity/Anorexiants; Stimulants Non-Narc Antitussive- Decongestant- Antihistamine Decongestant & Antihistamine Macrolides; Erythromycins Antidepressants; Selective Serotonin Reuptake Inhibitors Hypnotics; Non- Barbiturate Hypnotics; Benzodiazepine Hypnotics Antihistamines; Non- Sedating Antidepressants; Selective Serotonin Reuptake Inhibitors Added to the w/ PA Added to the w/ QL (62 /31 days) & AL (Min 6 ) Added to the Added to the Added to the Added to the Added to the Added to the Added to the Added to the fosphenytoin sodium 100 mg PE/2 ml injection Hydantoins Added to the gabapentin 250 mg/5 ml solution gemcitabine solution for injection all Antimetabolites Added to the w/ QL: 2230 ml/31 days Added to the w/ PA Page 2 of 18

3 Drug Name Therapeutic Class Change Alternative haloperidol ampules Antipyschotics/Antimani c Agents; Butyrophenones Added to the w/ AL (Min 3 ) hydrocodone polistirex/chlorpheniramine polistirex 10 mg - 8 mg/5 ml suspension haloperidol lactate oral solution 2 mg/ml solution for injection 5 mg/ml hydroxyzine hydrochloride 10 mg/5 ml syrup INVEGA SUSTENNA extended-release suspension for injection - all LEUCOVORIN CALCIUM - all levocarnitine 200 mg/ml vial levocetirizine 5 mg levocetirizine 2.5 mg/5 ml oral solution loratadine syrup/solution - all loratadine allergy relief - all lorazepam disp syringes, vials - all Opioid Antitussive- Antihistamine Antipyschotics/Antimani c Agents; Butyrophenones Antianxiety Agents Antipyschotics/Antimani c Agents; Benzisoxazoles Chemotherapy Rescue/Antidote Agents; Folic Acid Antagonists Rescue Agents Endocrine And Metabolic Agents - Misc.; Metabolic Modifiers; Carnitine Replenisher - Agents Antihistamines; Non- Sedating Antihistamines; Non- Sedating Antihistamines; Non- Sedating Antihistamines; Non- Sedating Added to the Added to the w/ AL (Min 3 ) Added to the Added to the w/ PA, AL (Min 18 ) & QL (1 syringe/28 days) Added to the Added to the Added to the Added to the w/ ST: T/F of loratadine solution AND cetirizine solution Added to the w/ QL (310 ml/31 days) Added to the Added to the Page 3 of 18

4 Drug Name Therapeutic Class Change Alternative meprobamate - all Antianxiety Agents Added to the methylin chew - all mirtazapine rapid - all nefazodone hydrochloride - all nortriptyline hydrochloride 10 mg/5ml solution PEGANONE 250 mg phenelzine sulfate 15 mg protriptyline hydrochloride - all selegiline hydrochloride 5 mg capsules SUPARTZ 1% solution for injection TRELSTAR solution for injection mg 22.5 mg TUSSICAPS extendedrelease capsules - all valproic acid solution - all zafirlukast - all ADHD/Anti- Narcolepsy/Anti- Obesity/Anorexiants; Stimulants Antidepressants;Alpha- 2 Receptor Antagonists (Tetracyclics) Antidepressants; Serotonin Modulators Antidepressants; Tricyclic Agents Hydantoins Antipyschotics/Antimani c Agents; Monoamine Oxidase Inhibitors Antidepressants; Tricyclic Agents Antiparkinson Agents; Antiparkinson Monoamine Oxidase Inhibitors Musculoskeletal Therapy Agents; Viscosupplements Antineoplastic - Hormonal and Related Agents; LHRH Analogs Opioid Antitussive- Antihistamine Valproic Acid Leukotriene Added to the w/ AL (Min 6 ) Added to the Added to the Added to the w/ QL (2325 ml/31 days) Added to the w/ QL: 372 /31 days Added to the Added to the Added to the Added to the w/ PA Added to the w/ PA Added to the Added to the Added to the Page 4 of 18

5 Modulators; Leukotriene Receptor Antagonists Drug Name Therapeutic Class Change Alternative ZYKADIA 150 mg capsules Antineoplastics And Adjunctive Therapy; Antineoplastic Enzyme Inhibitors; Antineoplastic - Tyrosine Kinase Inhibitors Added to the w/ PA and QL: 155 capsules/31 days UTILIZATION MANAGEMENT CHANGES ABILIFY solution, - all acamprosate calcium 333 mg delayed-release AFINITOR - all albuterol sulfate 5 mg/ ml nebulizer solution albuterol sulfate 2 mg/5 ml syrup albuterol sulfate 2.5 mg/3 ml nebulizer solution Antipyschotics/Antimani c Agents; Quinolone Derivatives Agents for Chemical Dependenc y; Alcohol Deterrents Antineoplastics Enzyme Inhibitors; Antineoplastic - mtor Kinase Inhibitors Sympathomimetics; Beta Adrenergics Sympathomimetics; Beta Adrenergics Sympathomimetics; Beta Adrenergics & QL, ST: (T/F of 2: risperidone, quetiapine, olanzapine) Updated QL: 186 /31 days Updated PA Updated QL: 60 ml/30 days Updated QL: 2480 ml/31 days Updated QL: 720 ml/31 days alprazolam - all amphetamine salt combo - all ADHD/Anti- Narcolepsy/Anti- Obesity/Anorexiants; Amphetamines;Amphet amine Mixtures, ST and QL Page 5 of 18

6 Drug Name Therapeutic Class Change Alternative ATROVENT HFA 17 mcg/ actaution inhalation aerosol Bronchodilators - Anticholinergics Updated QL: 25.8 gm/31 days benzonatate capsules - all BOSULIF 100 mg 500 mg budesonide suspension for inhalation - all bupropion hydrochloride sustained-release - all carbamazepine 100 mg/5 ml suspension chlorpromazine - all clorazepate - all COMBIVENT RESPIMAT 20 mcg-100 mcg/actuation inhalation solution cromolyn sodium 20 mg/2 ml nebulizer solution cyproheptadine hydrochloride 2 mg/5 ml syrup DELSYM controlled release liquid dextroamphetamine sulfate 5 mg Antitussive - Nonnarcotic Antineoplastics Enzyme Inhibitors; Tyrosine Kinase Inhibitors Steroid Inhalants Antidepressants Antipyschotics/ Antimanic Agents; Phenothiazines Sympathomimetics; Adrenergic Combinations Nasal Agents - Systemic and Topical; Nasal Antiallergy; Nasal Mast Cell Stabilizers Antihistamines; Piperidines Antitussive - Nonnarcotic ADHD/Anti- Narcolepsy/Anti- Obesity/Anorexiants; Updated PA Updated QL and AL: QL 120 ml/31 days and AL Max 8 Updated QL: 2480 ml/31 days Added AL: Min 6 months of age Added AL: Min 9 Updated QL: 4 gm/20 days Updated QL: 300 ml/31 days, ST and QL Page 6 of 18

7 10 mg Amphetamines Drug Name Therapeutic Class Change Alternative diazepam - all diazepam rectal gel - all divalproex sodium 500 mg extended-release divalproex sodium 250 mg extended-release divalproex sodium 500 mg delayed-release enteric coated divalproex sodium delayed-release enteric coated - all donepezil 10 mg 2.5 mg DULERA inhalation aerosol - all ethosuximide 250 mg/5 ml solution EXELON patches - all fluphenazine hydrochloride - all fluphenazine 2.5 mg/5 ml elixir fondaparinux sodium 2.5 mg/0.5 ml subcutaenous solution - Valproic Acid Valproic Acid Valproic Acid Valproic Acid Antidementia Agents; Cholinomimetics - ACHE Inhibitors Sympathomimetics; Adrenergic Combinations Succinimides Neurological Agents;Antidementia Agents;Cholinomimeti cs - ACHE Inhibitors Antipyschotics/ Antimanic Agents; Phenothiazines Antipsychotics/ Antimanic Agents; Phenothiazines Anticoagulants; Heparins and Heparinoid-Like Agents; Synthetic Heparinoid-Like Agents Updated QL: 3 each/31 days Updated QL: 279 /31 days Updated QL: 310 /31 days Updated QL: 279 /31 days Added QL: 13 gm/30 days Updated QL: 930 ml/31 days Updated AL: Min 18 Added QL: QL 2480 ml/31 days and AL: min 18 Updated QL: 16 ml/31 days Page 7 of 18

8 Drug Name Therapeutic Class Change Alternative fondaparinux sodium 5 mg/0.4 ml subcutaenous solution fondaparinux sodium 7.5 mg/0.6 ml subcutaenous solution fondaparinux sodium 10 mg/0.8 ml subcutaenous solution Anticoagulants; Heparins and Heparinoid-Like Agents; Synthetic Heparinoid-Like Agents Anticoagulants; Heparins and Heparinoid-Like Agents; Synthetic Heparinoid-Like Agents Anticoagulants; Heparins and Heparinoid-Like Agents; Synthetic Heparinoid-Like Agents Updated QL: 5.6 ml/31 days Updated QL: 8.4 ml/31 days Updated QL: ml/31 days FORADIL AEROLIZER 12 mcg capsules GLEEVEC - all guaifenesin - all guaifenesin liquid/solution haloperidol - all haloperidol decanoate ampules, vials - all hydrocodone bitartrate/homatropine methylbromide syrup, hydrocodone/apap 7.5 mg-650 mg 10 mg-650 mg 10 mg-660 mg hydrocodone/apap 10 mg-750 mg 7.5 mg-750 mg Sympathomimetics; Beta Adrenergics Antineoplastics Enzyme Inhibitors;Antineoplastic - Tyrosine Kinase Inhibitors Expectorants Expectorants Antipyschotics/ Antimanic Agents; Butyrophenones Antipyschotics/ Antimanic Agents; Butyrophenones Antitussive - Opioid Analgesics - Opioid;Opioid Combinations;Hydroco done Combinations Analgesics - Opioid;Opioid Combinations;Hydroco done Combinations Updated QL: 60 capsules/30 days Updated PA and Added AL: Min 3 Added AL: Min 18 Updated QL: 186 /31 days Updated QL: 165 /31 days Page 8 of 18

9 Drug Name Therapeutic Class Change Alternative ICLUSIG Antineoplastics Enzyme 15 mg Inhibitors;Antineoplastic 45 mg - Tyrosine Kinase Added PA Inhibitors ipratropium bromide/albuterol sulfate 0.5 mg-3 mg/3 ml nebulizer solution lamotrigine chew - all lamotrigine 25 mg lamotrigine 100 mg 150 mg 200 mg levetiracetam 250 mg levetiracetam 500 mg 750 mg 1000 mg levetiracetam 100 mg/ml solution lorazepam - all loxapine capsules - all megestrol 40 mg/ml suspension methylphenidate hydrochloride extendedrelease 18 mg 27 mg Antipyschotics/ Antimanic Agents; Dibenzapines Hormonal and Related Agents; Progestins - Antineoplastic ADHD/Anti- Narcolepsy/Anti- Obesity/Anorexiants; Stimulants Updated QL: 720 ml/31 days Updated QL: 310 /31 days Updated QL: 310 /31 days Updated QL: 372 /31 days Added AL: Min 18 Added QL: 600 ml/31 days Updated QL: 62 /31 days methylphenidate hydrochloride 10 mg extended-release ADHD/Anti- Narcolepsy/Anti- Obesity/Anorexiants; Stimulants & Updated AL: Min 6 Page 9 of 18

10 Drug Name Therapeutic Class Change Alternative methylphenidate hydrochloride 20 mg methylphenidate hydrochloride 5 mg 10 mg montelukast sodium 4 mg packets montelukast sodium, chewables - all NAMENDA solution,, tablet dosepak - all nicotine patches - all ORAP - all oxazepam capsules - all oxcarbazepine - all oxcarbazepine 300 mg/5 ml suspension perphenazine - all phenytoin suspension - all pramipexole dihydrochloride - all ADHD/Anti-Narcolepsy/ Anti-Obesity/ Anorexiants; Stimulants ADHD/Anti-Narcolepsy/ Anti-Obesity/ Anorexiants; Stimulants Leukotriene Modulators; Leukotriene Receptor Antagonists Leukotriene Modulators; Leukotriene Receptor Antagonists Antidementia Agents; N-Methyl-D-Aspartate (NMDA) Receptor Antagonists Smoking Deterrents Neurological Agents Antipyschotics/ Antimanic Agents; Phenothiazines Hydantoins Antiparkinson Agents; Antiparkinson Dopaminergics; Nonergoline Dopamine Updated QL: 93 /31 days and Added AL: Max 2 Updated QL: 70 patches/365 days Added AL: Min 12 Updated QL: 248 /31 days Added AL: Min 12 Updated QL: 930 ml/31 days Added ST: T/F ropinirole within the past 100 days. Page 10 of 18

11 Receptor Agonists Drug Name Therapeutic Class Change Alternative prochlorperazine maleate 10 mg 5 mg rectal suppository 25 mg PROLIA 60 mg/ml solution for injection PULMICORT suspension for inhalation - all quetiapine fumarate - all risperidone rapid - all rivastigmine capsules - all ROBITUSSIN CHILDRENS COUGH LONG-ACTING syrup SAPHRIS sublingual 10 mg 5 mg STIVARGA 40 mg SYMBICORT inhalation aerosol - all temazepam capsules - all Antipyschotics/Antimani c Agents; Phenothiazines Endocrine And Metabolic Agents - Misc.; Bone Density Regulators; RANK Ligand (RANKL) Inhibitors Steroid Inhalants Antipyschotics/ Antimanic Agents; Dibenzapines Antipyschotics/ Antimanic Agents;Benzisoxazoles Antidementia Agents; Cholinomimetics - ACHE Inhibitors Antitussive - Nonnarcotic Antipyschotics/ Antimanic Agents; Dibenzapines; Dibenzooxepino Pyrroles Antineoplastic Enzyme Inhibitors; Antineoplastic - Multikinase Inhibitors Sympathomimetics; Adrenergic Combinations Hypnotics;Non- Barbiturate; Added AL: Min 2 Removed ST and Added PA Updated QL and AL: QL 120 ml/31 days and AL Max 8 Added AL: Min 5, QL (62 /31 days) Added AL: Min 18 ; ST: (T/F of 2: risperidone, quetiapine, olanzapine) Updated PA Updated QL: 10.2 gm/30 days Page 11 of 18

12 Benzodiazepine Hypnotics Drug Name Therapeutic Class Change Alternative thioridazine - all thiothixene capsules - all tiagabine - all tizanidine - all triazolam - all trifluoperazine - all valproic acid syrup zolpidem tartrate 5 mg 10 mg ABILIFY vials, discmelts - all Antipyschotics/Antimani c Agents; Phenothiazines Antipyschotics/Antimani c Agents; Thioxanthenes GABA Modulators GABA Modulators Hypnotics;Non- Barbiturate Hypnotics; Benzodiazepine Hypnotics Antipyschotics/Antimani c Agents; Phenothiazines Valproic Acid Hypnotics;Non- Barbiturate Hypnotics; Non-Benzodiazepine - GABA-Receptor Modulators Added AL: Min 2 Added AL: Min 12 and Added ST: T/F of baclofen tabs AND cyclobenzaprine tabs & Added AL: Min 18 Added AL: Min 6 Updated QL: 2790 ml/31 days Added AL: Min 18 REMOVALS FROM THE Antipyschotics/Antimanic Agents;Quinolone Derivatives risperidone (QL,AL), quetiapine (QL,AL), olanzapine (QL,AL) AFINITOR DISPERZ for suspension - all Antineoplastics Enzyme Inhibitors; Antineoplastic - mtor Kinase Inhibitors AFINITOR (PA) aller-chlor 2 mg/5 ml syrup Antihistamines; Alkylamines CHLOR-TRIMETON BANZEL - all benztropine mesylate 2 mg/2 ml solution for Antiparkinson Agents; Antiparkinson lamotrigine (QL), divalproex (QL), topiramate (QL) trihexyphenidyl hydrochloride Page 12 of 18

13 injection Anticholinergics Drug Name Therapeutic Class Change Alternative BROTAPP liquid Decongestant & Antihistamine CHLOR-TRIMETON, pseudoephedrine caffeine citrate solution, vials - all ADHD/Anti-Narcolepsy /AntiObesity/Anorexiants ; Analeptics carbamazepine extended-release, capsules - all cetirizine hydrochloride chew - all Antihistamines; Non- Sedating carbamazepine immediate-release (QL) cetirizine hydrochloride hydrochloride syrup (QL) CHANTIX, dosepak - all Smoking Deterrents nicotine transdermal patch (QL) chlorpheniramine maleate controlled release - all Antihistamines; Alkylamines CHLOR-TRIMETON chlorpromazine 25 mg/ml solution for injection Antipyschotics/Antimanic Agents; Phenothiazines chlorpromazine hydrochloride oral citalopram hydrobromide 10 mg/5ml solution Antidepressants;Selectiv e Serotonin Reuptake Inhibitors citalopram hydrobromide oral clemastine fumarate - all Antihistamines; Ethanolamines clemastine fumarate oral syrup COMETRIQ capsules 60 mg 100 mg 140 mg CORICIDIN HBP COUGH & COLD cyclophosphamide powder for injection 500 mg 1 GM 2 GM Antineoplastics Enzyme Inhibitors; Antineoplastic - Tyrosine Kinase Inhibitors Antihistamine-Analgesic Adjunctive Therapies;Akylating Agents;Nitrogen Mustards BOSULIF (PA), CAPRELSA (PA) cyclophosphamide DILANTIN suspension, capsules - all Hydantoins phenytoin suspension, phenytoin capsules Page 13 of 18

14 Drug Name Therapeutic Class Change Alternative DILANTIN INFATABS 50 mg chew Hydantoins phenytoin suspension, phenytoin capsules DIMETAPP COLD & ALLERGY elixir Decongestant & Antihistamine CHLOR-TRIMETON entacapone 200 mg Antiparkinson Agents; Antiparkinson COMT Inhibitors; Peripheral COMT Inhibitors famotidine 10 mg/ml intravenous solution Ulcer Drugs; H-2 Antagonists ranitidine hydrochloride injection solution fludarabine phosphate solution for injection - all Antimetabolites flurazepam hydrochloride capsules - all Hypnotics;Non- Barbiturate Hypnotics; Benzodiazepine Hypnotics temazepam capsules FORFIVO 450 mg extended-release guaifenesin extendedrelease - all INCIVEK 375 mg Antidepressants Expectorants Antivirals; Hepatitis Agents; Hepatitis C Agents bupropion hydrochloride extended-release (XL) tablet 24 HR INLYTA 1 mg 5 mg Antineoplastics Enzyme Inhibitors; Antineoplastic - Tyrosine Kinase Inhibitors INTRON-A vials - all Antineoplastics Misc SYLATRON subcutaneous kit (PA) INTUNIV extendedrelease - all ADHD/Anti- Narcolepsy/Anti- Obesity/Anorexiants; Attention-Deficit/ Hyperactivity Disorder (ADHD); ADHD Agent - Selective Alpha Adrenergic Agonists Clonidine hydrochloride, guanfacine hydrochloride Page 14 of 18

15 Drug Name Therapeutic Class Change Alternative LAMICTAL starter kit, chew - all levalbuterol hydrochloride nebulizer solution - all LYRICA capsules, solution - all MATULANE 50 mg capsules methylphenidate hydrochloride extendedrelease (LA) capsules, extended-release 24 hr capsules - all Sympathomimetics; Beta Adrenergics Antineoplastics Misc ADHD/Anti-Narcolepsy/ Anti-Obesity/ Anorexiants;Stimulants lamotrigine oral tablet chewable (QL) albuterol sulfate inhalation nebulization solution (QL) gabapentin oral capsules (QL) methylphenidate hydrochloride extended-release oral (QL, AL) MUCINEX MAXIMUM STRENGTH Expectorants NEO-SYNEPHRINE Vasopressors AFRIN nasal spray solution NEXAVAR 200 mg Antineoplastic Enzyme Inhibitors; Antineoplastic - Multikinase Inhibitors NICOTROL 10 mg inhaler NICOTROL NS 0.5 mg/actuation nasal spray NOHIST-LQ liquid NOVOPEN device NUEDEXTA capsules Smoking Deterrents Smoking Deterrents Decongestant & Antihistamine Medical Devices; Parenteral Therapy Supplies; Needles & Syringes Pseudobulbar Affect (PBA) Agents; Pseudobulbar Affect nicotine transdermal patches (QL), nicotine polacrilex mouth/throat lozenges (QL) nicotine transdermal patches (QL), nicotine polacrilex mouth/throat lozenges (QL) Page 15 of 18

16 Agent Combinations Drug Name Therapeutic Class Change Alternative orphenadrine citrate 100 mg extended-release Musculoskeletal Therapy Agents; Central Muscle Relaxants cyclobenzaprine hydrochloride oral tablet (QL) phenobarbital 20 mg/5 ml elixir Hypnotics;Barbiturate Hypnotics phenobarbital 20 mg/5 ml oral solution PHENYTEK capsules - all Hydantoins phenytoin sodium extended-release oral capsules phenytoin infatabs 50 mg chew Hydantoins phenytoin sodium 50 mg chewable oral tablet POTIGA - all lamotrigine (QL), divalproex (QL), topiramate (QL), carbamazepine immediate release (QL) PRANDIMET - all Antidiabetics; Antidiabetic Combinations; Meglitinide-Biguanide Combinations PRANDIN - all Antidiabetics; Meglitinide Analogues PRISTIQ extendedrelease - all Antidepressants;Seroton in-norepinephrine Reuptake Inhibitors venlafaxine hydrochloride 24 hour extended-release capsule (QL) prochlorperazine edisylate solution for injection 10 mg/2 ml 5 mg/ml Antipyschotics/Antimanic Agents; Phenothiazines fluphenazine decanoate 25 mg/ml solution for injection PROMETHAZINE VC PLAIN syrup Decongestant & Antihistamine PULMICORT FLEXHALER powder for inhalation - all Steroid Inhalants FLOVENT diskus inhalation aerosol powder (QL) RA IBU-PROFEN COLD/SINUS Decongestant-Analgesic RISPERDAL CONSTA disp syringes - all Antipyschotics/Antimanic Agents; Benzisoxazoles INVEGA SUSTENNA intramuscular suspension (QL, AL) Page 16 of 18

17 Drug Name Therapeutic Class Change Alternative SABRIL, packets - all GABA Modulators tiagabine hydrochloride oral (ST) STRATTERA capsules - all ADHD/Anti-Narcolepsy/ Anti-Obesity/ Anorexiants; Attention- Deficit /Hyperactivity Disorder (ADHD); ADHD Agent - Selective Norepinephrine Reuptake Inhibitor methylphenidate hydrochloride extended-release oral (QL, AL) TARGRETIN 75 mg capsules Antineoplastic Misc; Selective Retinoid X Receptor Agonists TEGRETOL, suspension - all carbamazepine oral suspension, carbamazepine oral (QL) THEO-24 capsules - all Xanthines theophylline extendedrelease oral tobramycin 300 mg/5 ml nebulizer solution Aminoglycosides BETHKIS 300 mg/5 ml inhalation nebulization solution (PA) TRETINOIN 10 mg capsules Retinoids venlafaxine extendedrelease - all VIMPAT - all vitamin B-12 1,000 mcg Antidepressants;Seroton innorepinephrine Reuptake Inhibitors Hematopoietic Agents venlafaxine hydrochloride 24 hour extended-release capsule (QL) lamotrigine (QL), divalproex (QL), topiramate (QL), carbamazepine immediate release (QL) VOTRIENT 200 mg Enzyme Inhibitors; Tyrosine Kinase Page 17 of 18

18 Inhibitors Drug Name Therapeutic Class Change Alternative XENAZINE - all Movement Disorder Drug Therapy zaleplon capsules 5 mg 10 mg Hypnotics;Non- Barbiturate; Non- Benzodiazepine - GABA-Receptor Modulators zolpidem tartate (QL, AL) ziprasidone capsules - all Antipyschotics/Antimanic Agents; Antipsychotics risperidone (QL,AL), quetiapine (QL,AL), olanzapine (QL,AL) If you have questions, WellCare of South Carolina s Pharmacy Help Desk and its affiliated vendor, Catamaran, are available to assist providers seven days a week, 24 hours a day at Thank you for your care of WellCare of South Carolina Medicaid members. Sincerely, WellCare of South Carolina Page 18 of 18

Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs)

Ohana Community Care Services (CCS) Comprehensive Preferred Drug List (List of Covered Drugs) 2015 Ohana Community Care Services (CCS) Comprehensive referred Drug List (List of Covered Drugs) Ohana Health lan 00 lease read: This document contains information about the drugs we cover in this plan.

More information

UPDATE Ohana QUEST Integration Medicaid

UPDATE Ohana QUEST Integration Medicaid UPDATE Ohana QUEST Integration Medicaid Preferred Drug List June 29, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes

More information

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL* Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

More information

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100

More information

UPDATE WellCare s South Carolina

UPDATE WellCare s South Carolina September 3, 2015 UPDATE WellCare s South Carolina Preferred Drug List Dear Provider: At the September 3, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes

More information

Medicines Formulary BNF Section 4 Central Nervous System

Medicines Formulary BNF Section 4 Central Nervous System Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam

More information

U T I L I Z A T I O N E D I T S

U T I L I Z A T I O N E D I T S I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental

More information

Commissioner for the Department for Medicaid Services Selections for Preferred Products

Commissioner for the Department for Medicaid Services Selections for Preferred Products Commissioner for the Department for Medicaid Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Commissioner for the Department for

More information

UPDATE WellCare s New Jersey

UPDATE WellCare s New Jersey UPDATE WellCare s New Jersey Preferred Drug List July 13, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be

More information

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5

More information

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if

More information

CMI Marketplace 2015 (List of Covered Drugs)

CMI Marketplace 2015 (List of Covered Drugs) Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 fentanyl citrate 200 mcg lozenge hd morphine sulfate 30 mg tablet er oxymorphone hcl 7.5 mg tab er 12h Opioid Analgesics, Short-acting

More information

Alaska Medicaid 90 Day** Generic Prescription Medication List

Alaska Medicaid 90 Day** Generic Prescription Medication List 1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL

More information

South London and the Maudsley NHS Foundation Trust Medicines Formulary

South London and the Maudsley NHS Foundation Trust Medicines Formulary South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1

More information

WellCare s South Carolina Preferred Drug List Update

WellCare s South Carolina Preferred Drug List Update WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/03/2015.

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

Chapter 4 ~ Central nervous system

Chapter 4 ~ Central nervous system Chapter 4 ~ Central Nervous System: Special Section 1 of 5 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics LOPRAZOLAM Tablet 1mg LORMETAZEPAM Tablet 500microgram PROMETHAZINE

More information

CONTRAINDICATIONS TABLE

CONTRAINDICATIONS TABLE CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis

More information

NI Formulary: Chapter 4 Central Nervous system

NI Formulary: Chapter 4 Central Nervous system Hypnotics Anxiolytics Acute state Non drug treatment Temazepam tablets 10mg, 20mg; oral solution 10mg/5ml or Zolpidem tablets 5mg, 10mg or Zopiclone 3.75mg, 7.5mg Non drug treatment Diazepam tablets 2mg,

More information

UPDATE WellCare s South Carolina

UPDATE WellCare s South Carolina March 26, 2015 UPDATE WellCare s South Carolina Preferred Drug List Dear Provider: At the March 05, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will

More information

Appendix: Psychotropic Medication Reference Tables

Appendix: Psychotropic Medication Reference Tables Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Alprazolam 0.25mg, 0.5mg, 1mg tablets Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service

More information

NorthSTAR. Pharmacy Manual

NorthSTAR. Pharmacy Manual NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics

More information

UPDATE Ohana QUEST Integration Medicaid

UPDATE Ohana QUEST Integration Medicaid UPDATE Ohana QUEST Integration Medicaid Preferred Drug List March 26, 2015 Dear Provider: At the March 05, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019 VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 04/01/2019 Updated 03/2019 AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED

More information

WellCare s South Carolina Preferred Drug List Update

WellCare s South Carolina Preferred Drug List Update WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management

More information

UPDATE Georgia Medicaid

UPDATE Georgia Medicaid March 26, 2015 UPDATE Georgia Medicaid Preferred Drug List Dear Provider: At the March 05, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be made

More information

AHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016

AHCCCS BEHAVIORAL HEALTH DRUG LIST EFFECTIVE OCTOBER 1, 2016 Generic Drugs Are Preferred Over Brand Name Drugs Unless Specified As Brand Only Federally Reimbursable Drugs Not Listed On The AHCCCS Drug List Are Available Through Prior Authorization Effective Date

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension

More information

Formulary (Drug List)

Formulary (Drug List) Formulary (Drug List) PacificSource Community Solutions This list was updated on /5/07 Please Read: This document contains information about the drugs we cover on this plan. For a complete, up-to-date

More information

Retrospective Drug Use Review for the Use of Psychotropic Medications in Children

Retrospective Drug Use Review for the Use of Psychotropic Medications in Children Retrospective Drug Use Review for the Use of Psychotropic Medications in Children Recommendations Send providers an annual request for additional clinical data for children receiving any of the following

More information

Step Therapy Requirements. Effective: 03/01/2015

Step Therapy Requirements. Effective: 03/01/2015 Effective: 03/01/2015 Updated 02/2015 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA OXTELLAR XR POTIGA QUDEXY

More information

Step Therapy Requirements

Step Therapy Requirements Step Therapy Requirements Denver Health Medicare Choice (HMO SNP)/Medicare Select (HMO) Effective: 09/01/2017 Updated 08/2017 ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017 VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 01/01/2017 Updated 12/23/2016 ANTICONVULSANTS Aptiom 200 mg tablet Potiga 200 mg tablet Aptiom 400 mg tablet Potiga 300 mg tablet Aptiom

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG FYCOMPA 0.5 MG/ML ORAL SUSPENSION FYCOMPA 10 MG FYCOMPA 12 MG FYCOMPA

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS Acetaminophen 80mg/0.8mL Suspension Drops Acetaminophen 120mg Suppository Acetaminophen 160mg/5mL Suspension Acetaminophen 325mg Suppository Acetaminophen 325mg Tablet, Caplet, or Capsule Acetaminophen

More information

Chapter 4 ~ Central nervous system

Chapter 4 ~ Central nervous system Chapter 4 ~ Central Nervous System: General Section 1 of 6 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics CHLORAL HYDRATE CLOMETHIAZOLE NITRAZEPAM TEMAZEPAM TRICLOFOS

More information

TennCare Program TN MAC Price Change List As of: 03/30/2017

TennCare Program TN MAC Price Change List As of: 03/30/2017 1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

Did you know that some medications can be harmful to people 65 years or older?

Did you know that some medications can be harmful to people 65 years or older? Did you know that some medications can be harmful to people 65 years or older? What s the risk? Some medications can be dangerous to people 65 years of age or older. As we age, our bodies change. These

More information

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018 1 Tennessee CoverRx List Run : 04/26/18 Dosage Form amiodarone HCl 200 MG TABLET ORAL 04/25/2018 0.16102 0.14405 11.8 hydralazine HCl 100 MG TABLET ORAL 04/25/2015 0.11390 0.10854 4.9 hydralazine HCl 25

More information

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET APTIOM 800 MG TABLET BANZEL 200 MG TABLET BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG TABLET FYCOMPA 0.5 MG/ML ORAL SUSPENSION

More information

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 1 ANTICONVULSANTS

More information

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet Aptiom 800 mg tablet Banzel 200 mg tablet Banzel 40 mg/ml oral suspension Banzel 400 mg tablet Fycompa 0.5 mg/ml oral suspension

More information

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017 Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers This formulary is current as of February 11, 2010. Important Notes: Pharmacists must submit a claim on PharmaNet at the time

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:

More information

FirstCarolinaCare Insurance Company. Step Therapy Requirements

FirstCarolinaCare Insurance Company. Step Therapy Requirements FirstCarolinaCare Insurance Company Step Therapy Requirements Effective: 12/01/2018 ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION

More information

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E Santa Clara Family Health Plan Cal MediConnect Formulary List of Step Therapy Requirements Effective: 12/01/2018 13027.12E ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET

More information

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you

More information

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017 Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine

More information

Lungs SLO Practice (online) Page 1 of 5

Lungs SLO Practice (online) Page 1 of 5 Lungs SLO Practice (online) Page 1 of 5 1. A 15 year- old teen has asthma. A nebulizer treatment has been ordered. The type of medication most likely to be used in this treatment for asthma management

More information

Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay

Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay (Revised edition November 2015) The Medicine Related Falls Risk Assessment

More information

Aetna Better Health of Illinois Medicaid Formulary Updates

Aetna Better Health of Illinois Medicaid Formulary Updates October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary

More information

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication. ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE

More information

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE ODT TABLETS 15 MG REMERON SOL 90 30 MIRTAZAPINE ODT TABLETS 30 MG REMERON SOL 45 30 MIRTAZAPINE ODT TABLETS 45 MG REMERON SOL 30

More information

Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED

Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED Generic Drugs Are Over Brand Drugs Unless Specified As Brand ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE REMERON 30 30 MIRTAZAPINE REMERON SOLTAB 30 30 ISOCARBOXAZID TABLETS

More information

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017 Effective: 01/01/2017 Updated 11/2016 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA GABITRIL OXTELLAR XR POTIGA

More information

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015) WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015) **To get updated information about the drugs covered by WellCare/ Ohana, please visit our website (https://www.wellcare.com

More information

Provider Toolkit PFFS/PPO

Provider Toolkit PFFS/PPO Provider Toolkit 2014 2015 Y0067_PR_PhysTlkt_0514_IA 05/14/2014 PFFS/PPO TABLE OF CONTENTS Sample Letter from Physician to Patient...4 HEDIS Quick Reference Guide...5 High Risk Medication Formulary Alternative

More information

Safe transfer of prescribing guidance

Safe transfer of prescribing guidance Safe transfer of prescribing guidance TEWV Prescriber Summary Application required before prescribing Products requiring an application, before prescribing, using the single application form Unlicensed

More information

MO Medicaid Foster Care Drugs FY10-FY14

MO Medicaid Foster Care Drugs FY10-FY14 MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri

More information

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be

More information

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only ACAMPROSATE TABLET DELAYED RELEASE ALPHA-TOCOPHEROL CAPSULES ALPRAZOLAM CONCENTRATE 1 MG/ML ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG ALPRAZOLAM ODT TABLET 2MG ALPRAZOLAM SR TABLET 24-HOUR ALPRAZOLAM TABLET

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the

More information

Drugs Found in Medical Examiner Cases

Drugs Found in Medical Examiner Cases s Found in Medical Examiner Cases 1,1 difluoroethane propellant in aerosols 10-Hydroxycarbazepine 11-Hydroxy Delta-9 THC 6-monoacetylmorphine 7-amino clonazepam acetaminophen acetone alpha-hydroxyalprazolam

More information

Formulary for the JHM Outpatient Medication Assistance Program (OMAP)

Formulary for the JHM Outpatient Medication Assistance Program (OMAP) Note: The JHM Outpatient is a clinic-based program and may only be used by outpatient clinics and JHCP sites approved to participate in the program. To be eligible for OMAP, the patient must not have any

More information

Use of Psychotropic Medications in Older Adults with Dementia!

Use of Psychotropic Medications in Older Adults with Dementia! Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with

More information

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

More information

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5

More information

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Drug List Changes - UPDATE Note: This article was previously published in the December 2014 Medicaid

More information

Adapted from: Best Practices for Medication Management for Children & Adolescents in Foster Care. October 2015

Adapted from: Best Practices for Medication Management for Children & Adolescents in Foster Care. October 2015 Adapted from: Best Practices for Medication Management for Children & Adolescents in Foster Care October 2015 Psychotropic Medications Key Information Purpose: This document is designed for any reader

More information

News & Views. Maryland Medicaid Mental Health Formulary Revisions. Responsible use of Intervention and Outcome Codes

News & Views. Maryland Medicaid Mental Health Formulary Revisions. Responsible use of Intervention and Outcome Codes Maryland Medicaid Pharmacy Program News & Views June 2009 Maryland Department of Health and Mental Hygiene / Office of Systems, Operations and Pharmacy Maryland Medicaid Mental Health Formulary Revisions

More information

PL CE LIVE February 2011 Forum

PL CE LIVE February 2011 Forum February 2011 PL CE LIVE Kristin W. Weitzel, Pharm.D., CDE, FAPhA Associate Editor and Director of Editorial Projects Pharmacist s Letter/Prescriber s Letter Atypical Antipsychotics Atypical Antipsychotics

More information

Oral Agents. Fml Limits. Available Strengths NF NF

Oral Agents. Fml Limits. Available Strengths NF NF MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Allergy Medications LAST REVIEW: 9/12/2017 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 9/16, 5/15, 9/14

More information

Prescriber s Guide. Stahl s Essential Psychopharmacology

Prescriber s Guide. Stahl s Essential Psychopharmacology Stahl s Essential Psychopharmacology Prescriber s Guide FIFTH EDITION With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present this

More information

ALLERGIC CONJUNCTIVITIS AGENTS

ALLERGIC CONJUNCTIVITIS AGENTS 2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops

More information

North Dakota Medicaid Therapeutic Duplication Edits

North Dakota Medicaid Therapeutic Duplication Edits North Dakota Medicaid Therapeutic Duplication Edits This document is meant to serve as a guide to ND Medicaid s Therapeutic Duplication Edit which is reported as NCPDP Reject Code: 88 DUR REJECT ERROR.

More information

Oakwood Healthcare Low Cost Drug List for OHSCare & BCN

Oakwood Healthcare Low Cost Drug List for OHSCare & BCN Oakwood Healthcare Low Cost Drug List for OHSCare & BCN ACETAMINOPHEN-CODEINE ELIXIR Analgesic 240 720 ACYCLOVIR CAP 200MG Antiviral 30 90 AKTOB 0.3% EYE DROPS Miscellaneous 5 15 ALBUTEROL INH SOL 0.083%

More information

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get

More information

Allergy: Levocetirizine (Xyzal) (F) Desloratadine (Clarinex) (NF) OTC Cetirizine (Zyrtec) (NF) OTC Loratadine (Claritin) (NF) Dexchlorpheniramine

Allergy: Levocetirizine (Xyzal) (F) Desloratadine (Clarinex) (NF) OTC Cetirizine (Zyrtec) (NF) OTC Loratadine (Claritin) (NF) Dexchlorpheniramine Anticholinergics Brompheniramine Carbinoxamine Chlorpheniramine Clemastine Cyproheptadine Highly anticholinergic, clearance reduced with advanced age, and tolerance develops when used as hypnotic; greater

More information

Part ONE Answer ALL questions. Write the correct answer CLEARLY in the answer grid provided.

Part ONE Answer ALL questions. Write the correct answer CLEARLY in the answer grid provided. UNIVERSITY OF EAST ANGLIA School of Pharmacy Main Series UG Examination 2012-2013 CLINICAL THERAPEUTICS 7: PSYCHIATRY PHA-MHBY Time allowed: 2 hours Part ONE Answer ALL questions. Write the correct answer

More information

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018 TEST Network Health Insurance Corporation NetworkCares Step Therapy Last Updated 11/2018 ANTICONVULSANT THERAPY Aptiom Banzel Briviact Celontin Dilantin 30 Mg Capsule Equetro Fycompa 0.5 Mg/ml Oral Susp

More information

2017 Step Therapy Criteria

2017 Step Therapy Criteria FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.

More information

Medicine Related Falls Risk Assessment Tool (MRFRAT)

Medicine Related Falls Risk Assessment Tool (MRFRAT) Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus and Anthem HealthKeepers Plus, Commonwealth Coordinated Care Plus (Anthem CCC Plus) members. These formulary changes,

More information